Themis Bioscience
ID: 5865100A biotechnology company developing immune-modulation therapies for infectious diseases and cancer leveraging its technology platform and understanding of immune system mechanisms. It was founded in 2009 and is located in Vienna, Austria.
3
Funding Rounds
$68.0m
Money raised
Recent Funding Rounds
Overview
Unlock Complete Company Intelligence
Access comprehensive data and insights available only to Seedtable members
Financial Details
- • Complete funding history and valuations
- • Revenue estimates and financial metrics
- • Investment round details and terms
People & Contacts
- • Complete leadership team profiles
- • Contact information and email addresses
- • Board members and advisors
Market Intelligence
- • Competitive landscape analysis
- • Market position and growth metrics
- • Industry benchmarking data
Premium Tools
- • Export data and generate reports
- • Save companies to custom watchlists
- • API access for data integration
Join 10,000+ Professionals
Trusted by investors, founders, and analysts worldwide
Access detailed insights on 71,000+ companies worldwide
| Name | Phone | Social networks | |
|---|---|---|---|
| Dr* Er*** Ta**** | - | - | - |
Funding series
Funding Series Analysis
The company Themis Bioscience has raised a total of $12m in funding over 3 rounds.
Key Insights:
- Themis Bioscience Series C round, January 2017: $12m
- Themis funding round, January 2018: $12m
- Themis Bioscience funding round, September 2019: $44m